Ohio Public Employees Retirement System (OPERS)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.29M Buy
59,895
+988
+2% +$54.3K 0.01% 859
2025
Q1
$4.16M Sell
58,907
-6,576
-10% -$465K 0.02% 732
2024
Q4
$4.3M Sell
65,483
-3,630
-5% -$239K 0.01% 766
2024
Q3
$4.86M Sell
69,113
-6,819
-9% -$479K 0.02% 685
2024
Q2
$6.25M Sell
75,932
-1,549
-2% -$128K 0.02% 518
2024
Q1
$6.77M Sell
77,481
-8,268
-10% -$722K 0.03% 516
2023
Q4
$8.27M Buy
85,749
+722
+0.8% +$69.6K 0.03% 439
2023
Q3
$7.52M Sell
85,027
-8,435
-9% -$746K 0.03% 424
2023
Q2
$8.1M Sell
93,462
-7,075
-7% -$613K 0.03% 439
2023
Q1
$9.78M Buy
100,537
+5,525
+6% +$537K 0.04% 393
2022
Q4
$9.83M Buy
95,012
+1,128
+1% +$117K 0.04% 383
2022
Q3
$7.96M Buy
93,884
+711
+0.8% +$60.3K 0.04% 426
2022
Q2
$7.72M Sell
93,173
-2,923
-3% -$242K 0.03% 463
2022
Q1
$7.41M Sell
96,096
-3,251
-3% -$251K 0.03% 569
2021
Q4
$8.78M Sell
99,347
-3,596
-3% -$318K 0.03% 516
2021
Q3
$7.96M Sell
102,943
-2,133
-2% -$165K 0.03% 544
2021
Q2
$8.77M Buy
105,076
+6,405
+6% +$534K 0.03% 520
2021
Q1
$7.45M Buy
98,671
+7,211
+8% +$545K 0.03% 534
2020
Q4
$8.02M Buy
91,460
+17,317
+23% +$1.52M 0.04% 436
2020
Q3
$5.64M Buy
74,143
+4,661
+7% +$355K 0.03% 454
2020
Q2
$8.57M Sell
69,482
-3,157
-4% -$389K 0.05% 342
2020
Q1
$6.14M Buy
72,639
+10,979
+18% +$928K 0.04% 378
2019
Q4
$5.21M Buy
61,660
+780
+1% +$65.9K 0.03% 524
2019
Q3
$4.1M Buy
60,880
+288
+0.5% +$19.4K 0.02% 638
2019
Q2
$5.19M Sell
60,592
-3,414
-5% -$292K 0.03% 532
2019
Q1
$5.69M Sell
64,006
-12,169
-16% -$1.08M 0.03% 521
2018
Q4
$6.49M Sell
76,175
-4,823
-6% -$411K 0.04% 415
2018
Q3
$7.85M Sell
80,998
-3,069
-4% -$298K 0.04% 441
2018
Q2
$7.92M Sell
84,067
-3,991
-5% -$376K 0.04% 446
2018
Q1
$7.14M Sell
88,058
-18,730
-18% -$1.52M 0.04% 475
2017
Q4
$9.52M Buy
106,788
+126
+0.1% +$11.2K 0.05% 385
2017
Q3
$9.93M Sell
106,662
-2,333
-2% -$217K 0.05% 359
2017
Q2
$9.9M Sell
108,995
-7,505
-6% -$682K 0.05% 360
2017
Q1
$10.2M Hold
116,500
0.06% 352
2016
Q4
$10.5M Buy
116,500
+5,281
+5% +$474K 0.06% 346
2016
Q3
$10.3M Buy
111,219
+23,238
+26% +$2.15M 0.06% 316
2016
Q2
$6.85M Buy
87,981
+7,047
+9% +$548K 0.04% 401
2016
Q1
$6.68M Buy
80,934
+18,787
+30% +$1.55M 0.04% 396
2015
Q4
$6.51M Sell
62,147
-16,244
-21% -$1.7M 0.04% 426
2015
Q3
$8.26M Sell
78,391
-8,780
-10% -$925K 0.05% 365
2015
Q2
$11.9M Buy
87,171
+8,647
+11% +$1.18M 0.07% 315
2015
Q1
$9.79M Buy
78,524
+26,524
+51% +$3.31M 0.06% 361
2014
Q4
$4.7M Buy
52,000
+11,054
+27% +$999K 0.03% 573
2014
Q3
$2.96M Sell
40,946
-3,188
-7% -$230K 0.02% 725
2014
Q2
$2.75M Sell
44,134
-3,706
-8% -$231K 0.02% 789
2014
Q1
$3.26M Sell
47,840
-9,504
-17% -$648K 0.02% 689
2013
Q4
$4.03M Buy
57,344
+6,506
+13% +$457K 0.02% 670
2013
Q3
$3.67M Buy
50,838
+9,212
+22% +$665K 0.02% 719
2013
Q2
$2.32M Buy
+41,626
New +$2.32M 0.01% 844